{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:19:58Z","timestamp":1789870798852,"version":"4.0.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13024-015-0046-3","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T09:16:54Z","timestamp":1443518214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16\/FOXO target gene expression"],"prefix":"10.1186","volume":"10","author":[{"given":"Xi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah V.","family":"McCue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Quan","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhanva S.","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff W.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D.","family":"Burgoyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,29]]},"reference":[{"key":"46_CR1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nchembio.1663","volume":"10","author":"P Narayan","year":"2014","unstructured":"Narayan P, Ehsani S, Lindquist S. Combating neurodegenerative disease with chemical probes and model systems. Nat Chem Biol. 2014;10:911\u201320.","journal-title":"Nat Chem Biol"},{"key":"46_CR2","doi-asserted-by":"crossref","first-page":"9368","DOI":"10.1073\/pnas.92.20.9368","volume":"92","author":"CD Link","year":"1995","unstructured":"Link CD. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1995;92:9368\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1353-8020(00)00056-0","volume":"7","author":"R Nass","year":"2001","unstructured":"Nass R, Miller DM, Blakely RD. C. elegans: a novel pharmacogenetic model to study Parkinson\u2019s disease. Parkinsonism Relat Disord. 2001;7:185\u201391.","journal-title":"Parkinsonism Relat Disord"},{"key":"46_CR4","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1073\/pnas.100107297","volume":"97","author":"SH Satyal","year":"2000","unstructured":"Satyal SH, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer JM, et al. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2000;97:5750\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/emmm.200900051","volume":"1","author":"TJ Ham van","year":"2009","unstructured":"van Ham TJ, Breitling R, Swertz MA, Nollen EA. Neurodegenerative diseases: lessons from genome-wide screens in small model organisms. EMBO Mol Med. 2009;1:360\u201370.","journal-title":"EMBO Mol Med"},{"key":"46_CR6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2164-13-71","volume":"13","author":"X Chen","year":"2012","unstructured":"Chen X, Burgoyne RD. Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms. BMC Genomics. 2012;13:71.","journal-title":"BMC Genomics"},{"key":"46_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1087057113499777","volume":"19","author":"M Zhang","year":"2014","unstructured":"Zhang M, Luo G, Zhou Y, Wang S, Zhong Z. Phenotypic screens targeting neurodegenerative diseases. J Biomol Screen. 2014;19:1\u201316.","journal-title":"J Biomol Screen"},{"key":"46_CR8","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nrd3869","volume":"11","author":"A Corbett","year":"2012","unstructured":"Corbett A, Pickett J, Burns A, Corcoran J, Dunnett SB, Edison P, et al. Drug repositioning for Alzheimer\u2019s disease. Nat Rev Drug Discov. 2012;11:833\u201346.","journal-title":"Nat Rev Drug Discov"},{"key":"46_CR9","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.ddtec.2012.02.002","volume":"10","author":"A Lublin","year":"2013","unstructured":"Lublin A, Link C. Alzheimer\u2019s disease drug discovery: screening using as a model for beta-amyloid peptide-induced toxicity. Drug Discov Today Technol. 2013;10:e115\u20139.","journal-title":"Drug Discov Today Technol"},{"key":"46_CR10","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.biopsych.2012.08.027","volume":"73","author":"AV McCormick","year":"2013","unstructured":"McCormick AV, Wheeler JM, Guthrie CR, Liachko NF, Kraemer BC. Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity. Biol Psychiatry. 2013;73:464\u201371.","journal-title":"Biol Psychiatry"},{"key":"46_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/hmg\/ddq459","volume":"20","author":"JN Sleigh","year":"2011","unstructured":"Sleigh JN, Buckingham SD, Esmaeili B, Viswanathan M, Cuppen E, Westlund BM, et al. A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds. Hum Mol Genet. 2011;20:245\u201360.","journal-title":"Hum Mol Genet"},{"key":"46_CR12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/B978-0-12-384878-9.00015-7","volume":"100","author":"B Wolozin","year":"2011","unstructured":"Wolozin B, Gabel C, Ferree A, Guillily M, Ebata A. Watching worms whither: modeling neurodegeneration in C. elegans. Prog Mol Biol Transl Sci. 2011;100:499\u2013514.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"46_CR13","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1371\/journal.pone.0000504","volume":"2","author":"C Voisine","year":"2007","unstructured":"Voisine C, Varma H, Walker N, Bates EA, Stockwell BR, Hart AC. Identification of potential therapeutic drugs for huntington\u2019s disease using Caenorhabditis elegans. PLoS One. 2007;2:e504.","journal-title":"PLoS One"},{"key":"46_CR14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1534","volume":"37","author":"JA Parker","year":"2005","unstructured":"Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, et al. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat Genet. 2005;37:349\u201350.","journal-title":"Nat Genet"},{"key":"46_CR15","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.neurobiolaging.2013.03.014","volume":"34","author":"A Tauffenberger","year":"2013","unstructured":"Tauffenberger A, Julien C, Parker JA. Evaluation of longevity enhancing compounds against transactive response DNA-binding protein-43 neuronal toxicity. Neurobiol Aging. 2013;34:2175\u201382.","journal-title":"Neurobiol Aging"},{"key":"46_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","volume":"54","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease. Neurochem Int. 2009;54:111\u20138.","journal-title":"Neurochem Int"},{"key":"46_CR17","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1523\/JNEUROSCI.5831-09.2010","volume":"30","author":"N Bizat","year":"2010","unstructured":"Bizat N, Peyrin JM, Haik S, Cochois V, Beaudry P, Laplanche JL, et al. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci. 2010;30:5394\u2013403.","journal-title":"J Neurosci"},{"key":"46_CR18","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1093\/hmg\/ddu316","volume":"23","author":"SS Kashyap","year":"2014","unstructured":"Kashyap SS, Johnson JR, McCue HV, Chen X, Edmonds MJ, Ayala M, et al. Caenorhabditis elegans dnj-14, the orthologue of the DNAJC5 gene mutated in adult onset neuronal ceroid lipofuscinosis, provides a new platform for neuroprotective drug screening and identifies a SIR-2.1-independent action of resveratrol. Hum Mol Genet. 2014;23:5916\u201327.","journal-title":"Hum Mol Genet"},{"key":"46_CR19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajhg.2011.07.003","volume":"89","author":"L Noskova","year":"2011","unstructured":"Noskova L, Stranecky V, Hartmannova H, Pristoupilova A, Baresova V, Ivanek R, et al. Mutations in DNAJC5, encoding cysteine-string protein alpha, cause autosomal-dominant adult-onset neuronal ceroid lipofuscinosis. Am J Hum Genet. 2011;89:241\u201352.","journal-title":"Am J Hum Genet"},{"key":"46_CR20","doi-asserted-by":"crossref","first-page":"e26741","DOI":"10.1371\/journal.pone.0026741","volume":"6","author":"BA Benitez","year":"2011","unstructured":"Benitez BA, Alvarado D, Cai Y, Mayo K, Chakraverty S, Norton J, et al. Exome-sequencing confirms DNAJC5 mutations as cause of adult neuronal ceroid-lipofuscinosis. PLoS One. 2011;6:e26741.","journal-title":"PLoS One"},{"key":"46_CR21","doi-asserted-by":"crossref","first-page":"e29729","DOI":"10.1371\/journal.pone.0029729","volume":"7","author":"M Velinov","year":"2012","unstructured":"Velinov M, Dolzhanskaya N, Gonzalez M, Powell E, Konidari I, Hulme W, et al. Mutations in the gene DNAJC5 cause autosomal dominant Kufs disease in a proportion of cases: study of the Parry family and 8 other families. PLoS One. 2012;7:e29729.","journal-title":"PLoS One"},{"key":"46_CR22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/cge.12020","volume":"83","author":"M Cadieux-Dion","year":"2013","unstructured":"Cadieux-Dion M, Andermann E, Lachance-Touchette P, Ansorge O, Meloche C, Barnabe A, et al. Recurrent mutations in DNAJC5 cause autosomal dominant Kufs disease. Clin Genet. 2013;83:571\u20135.","journal-title":"Clin Genet"},{"key":"46_CR23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.8310297","volume":"263","author":"KE Zinsmaier","year":"1994","unstructured":"Zinsmaier KE, Eberle KK, Buchner E, Walter N, Benzer S. Paralysis and early death in cysteine string protein mutants of Drosophila. Science. 1994;263:977\u201380.","journal-title":"Science"},{"key":"46_CR24","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1046\/j.1471-4159.2000.0741781.x","volume":"74","author":"LH Chamberlain","year":"2000","unstructured":"Chamberlain LH, Burgoyne RD. Cysteine-string protein: the chaperone at the synapse. J Neurochem. 2000;74:1781\u20139.","journal-title":"J Neurochem"},{"key":"46_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ncb2131","volume":"13","author":"M Sharma","year":"2011","unstructured":"Sharma M, Burre J, Sudhof TC. CSPalpha promotes SNARE-complex assembly by chaperoning SNAP-25 during synaptic activity. Nat Cell Biol. 2011;13:30\u20139.","journal-title":"Nat Cell Biol"},{"key":"46_CR26","doi-asserted-by":"crossref","first-page":"147ra113","DOI":"10.1126\/scitranslmed.3004028","volume":"4","author":"M Sharma","year":"2012","unstructured":"Sharma M, Burre J, Sudhof TC. Proteasome inhibition alleviates SNARE-dependent neurodegeneration. Sci Transl Med. 2012;4:147ra113.","journal-title":"Sci Transl Med"},{"key":"46_CR27","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ncb0111-8","volume":"13","author":"RD Burgoyne","year":"2011","unstructured":"Burgoyne RD, Morgan A. Chaperoning the SNAREs: a role in preventing neurodegeneration? Nat Cell Biol. 2011;13:8\u20139.","journal-title":"Nat Cell Biol"},{"key":"46_CR28","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0896-6273(04)00190-4","volume":"42","author":"R Fernandez-Chacon","year":"2004","unstructured":"Fernandez-Chacon R, Wolfel M, Nishimune H, Tabares L, Schmitz F, Castellano-Munoz M, et al. The synaptic vesicle protein CSP alpha prevents presynaptic degeneration. Neuron. 2004;42:237\u201351.","journal-title":"Neuron"},{"key":"46_CR29","doi-asserted-by":"crossref","first-page":"9980","DOI":"10.1073\/pnas.1533448100","volume":"100","author":"BC Kraemer","year":"2003","unstructured":"Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A. 2003;100:9980\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1535-7597.2002.00024.x","volume":"2","author":"V Crunelli","year":"2002","unstructured":"Crunelli V, Leresche N. Block of thalamic T-type Ca(2+) channels by ethosuximide is not the whole story. Epilepsy Curr. 2002;2:53\u20136.","journal-title":"Epilepsy Curr"},{"key":"46_CR31","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1242\/jeb.01616","volume":"208","author":"KA Steger","year":"2005","unstructured":"Steger KA, Shtonda BB, Thacker C, Snutch TP, Avery L. The C. elegans T-type calcium channel CCA-1 boosts neuromuscular transmission. J Exp Biol. 2005;208:2191\u2013203.","journal-title":"J Exp Biol"},{"key":"46_CR32","doi-asserted-by":"crossref","first-page":"B215","DOI":"10.1093\/gerona\/55.5.B215","volume":"55","author":"D Gems","year":"2000","unstructured":"Gems D, Riddle DL. Defining wild-type life span in Caenorhabditis elegans. J Gerontol A Biol Sci Med Sci. 2000;55:B215\u20139.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"46_CR33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cell.2013.02.035","volume":"153","author":"F Cabreiro","year":"2013","unstructured":"Cabreiro F, Au C, Leung KY, Vergara-Irigaray N, Cocheme HM, Noori T, et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell. 2013;153:228\u201339.","journal-title":"Cell"},{"key":"46_CR34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature01789","volume":"424","author":"CT Murphy","year":"2003","unstructured":"Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424:277\u201383.","journal-title":"Nature"},{"key":"46_CR35","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0960-9822(01)00594-2","volume":"11","author":"ST Henderson","year":"2001","unstructured":"Henderson ST, Johnson TE. Daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol. 2001;11:1975\u201380.","journal-title":"Curr Biol"},{"key":"46_CR36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ceb.2008.02.005","volume":"20","author":"DA Salih","year":"2008","unstructured":"Salih DA, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol. 2008;20:126\u201336.","journal-title":"Curr Opin Cell Biol"},{"key":"46_CR37","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.3390\/ijms14046614","volume":"14","author":"ML Kang","year":"2013","unstructured":"Kang ML, Kwon JS, Kim MS. Induction of neuronal differentiation of rat muscle-derived stem cells in vitro using basic fibroblast growth factor and ethosuximide. Int J Mol Sci. 2013;14:6614\u201323.","journal-title":"Int J Mol Sci"},{"key":"46_CR38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cell.2013.06.003","volume":"154","author":"SH Park","year":"2013","unstructured":"Park SH, Kukushkin Y, Gupta R, Chen T, Konagai A, Hipp MS, et al. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell. 2013;154:134\u201345.","journal-title":"Cell"},{"key":"46_CR39","doi-asserted-by":"crossref","first-page":"e1000230","DOI":"10.1371\/journal.pgen.1000230","volume":"4","author":"JJ Collins","year":"2008","unstructured":"Collins JJ, Evason K, Pickett CL, Schneider DL, Kornfeld K. The anticonvulsant ethosuximide disrupts sensory function to extend C elegans lifespan. PLoS Genet. 2008;4:e1000230.","journal-title":"PLoS Genet"},{"key":"46_CR40","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1126\/science.282.5396.2028","volume":"282","author":"CI Bargmann","year":"1998","unstructured":"Bargmann CI. Neurobiology of the Caenorhabditis elegans genome. Science. 1998;282:2028\u201333.","journal-title":"Science"},{"key":"46_CR41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.1105299","volume":"307","author":"K Evason","year":"2005","unstructured":"Evason K, Huang C, Yamben I, Covey DF, Kornfeld K. Anticonvulsant medications extend worm life-span. Science. 2005;307:258\u201362.","journal-title":"Science"},{"key":"46_CR42","doi-asserted-by":"crossref","first-page":"e82543","DOI":"10.1371\/journal.pone.0082543","volume":"8","author":"H Choi","year":"2013","unstructured":"Choi H, Schneider H, Klum S, Chandler-Brown D, Kaeberlein M, Shamieh L. UV-Photoconversion of ethosuximide from a longevity-promoting compound to a potent toxin. PLoS One. 2013;8:e82543.","journal-title":"PLoS One"},{"key":"46_CR43","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1126\/science.1124646","volume":"313","author":"E Cohen","year":"2006","unstructured":"Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A. Opposing activities protect against age-onset proteotoxicity. Science. 2006;313:1604\u201310.","journal-title":"Science"},{"key":"46_CR44","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/hmg\/ddr076","volume":"20","author":"T Zhang","year":"2011","unstructured":"Zhang T, Mullane PC, Periz G, Wang J. TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin\/IGF-1 signaling. Hum Mol Genet. 2011;20:1952\u201365.","journal-title":"Hum Mol Genet"},{"key":"46_CR45","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.152161099","volume":"99","author":"JF Morley","year":"2002","unstructured":"Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2002;99:10417\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"46_CR46","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.cell.2009.11.014","volume":"139","author":"E Cohen","year":"2009","unstructured":"Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G, et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell. 2009;139:1157\u201369.","journal-title":"Cell"},{"key":"46_CR47","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2013.07.006","volume":"154","author":"RG Tepper","year":"2013","unstructured":"Tepper RG, Ashraf J, Kaletsky R, Kleemann G, Murphy CT, Bussemaker HJ. PQM-1 complements DAF-16 as a key transcriptional regulator of DAF-2-mediated development and longevity. Cell. 2013;154:676\u201390.","journal-title":"Cell"},{"key":"46_CR48","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01036","volume":"419","author":"GJ Kops","year":"2002","unstructured":"Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316\u201321.","journal-title":"Nature"},{"key":"46_CR49","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1523\/JNEUROSCI.1805-09.2009","volume":"29","author":"J Mojsilovic-Petrovic","year":"2009","unstructured":"Mojsilovic-Petrovic J, Nedelsky N, Boccitto M, Mano I, Georgiades SN, Zhou W, et al. FOXO3a is broadly neuroprotective in vitro and in vivo against insults implicated in motor neuron diseases. J Neurosci. 2009;29:8236\u201347.","journal-title":"J Neurosci"},{"key":"46_CR50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H, West T, et al. Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med. 2012;18:153\u20138.","journal-title":"Nat Med"},{"key":"46_CR51","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/hmg\/ddt530","volume":"23","author":"E Pino","year":"2014","unstructured":"Pino E, Amamoto R, Zheng L, Cacquevel M, Sarria JC, Knott GW, et al. FOXO3 determines the accumulation of alpha-synuclein and controls the fate of dopaminergic neurons in the substantia nigra. Hum Mol Genet. 2014;23:1435\u201352.","journal-title":"Hum Mol Genet"},{"key":"46_CR52","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1527-3458.2007.00009.x","volume":"13","author":"MZ Goren","year":"2007","unstructured":"Goren MZ, Onat F. Ethosuximide: from bench to bedside. CNS Drug Rev. 2007;13:224\u201339.","journal-title":"CNS Drug Rev"},{"key":"46_CR53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/1471-2164-15-841","volume":"15","author":"MJ Edmonds","year":"2014","unstructured":"Edmonds MJ, Morgan A. A systematic analysis of protein palmitoylation in Caenorhabditis elegans. BMC Genomics. 2014;15:841.","journal-title":"BMC Genomics"},{"key":"46_CR54","doi-asserted-by":"crossref","first-page":"e31849","DOI":"10.1371\/journal.pone.0031849","volume":"7","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Chen D, Smith MA, Zhang B, Pan X. Selection of reliable reference genes in Caenorhabditis elegans for analysis of nanotoxicity. PLoS One. 2012;7:e31849.","journal-title":"PLoS One"},{"key":"46_CR55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc Ser B-Methodol. 1995;57:289\u2013300.","journal-title":"J R Stat Soc Ser B-Methodol"}],"updated-by":[{"DOI":"10.1186\/s13024-015-0051-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T00:00:00Z","timestamp":1445558400000}}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-015-0046-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T12:46:38Z","timestamp":1718109998000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.molecularneurodegeneration.com\/content\/10\/1\/51"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,29]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1186\/s13024-015-0046-3","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,29]]},"article-number":"51"}}